Plain-English translation of NCT06818370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether coconut oil can help prevent or reduce hair loss in women with breast cancer who are receiving chemotherapy with doxorubicin and cyclophosphamide. Hair loss is a common and distressing side effect of these chemotherapy drugs. The study will compare women who apply coconut oil to their scalp weekly with women who don't use any scalp treatment, to see if the medication helps preserve hair.
Hair loss from chemotherapy can be emotionally difficult for patients, but there is limited research on simple, natural ways to prevent it. This study aims to fill that gap by testing whether coconut oil—which may nourish damaged hair and scalp—can help reduce this side effect.
You likely qualify if…
You likely don't qualify if…
At the start, you'll fill out a brief form about your health and background. If you're in the coconut oil group, you'll apply 10 milliliters (about 2 teaspoons) of coconut oil to your scalp once a week during your chemotherapy. If you're in the control group, you'll continue your normal hair care without any special treatment. Every week, a researcher will assess and measure any hair loss you experience using a standard evaluation tool. The study continues throughout your chemotherapy treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Collaborators
Çankırı Karatekin University
Enrollment target
~86 participants
Started
February 2025
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Sex
Female only
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
İsmail Dakdevir, Nurse
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.